You are about to leave the Clinical Value website now.

Cancel
Screenshot 2023 10 02 100520

Patient-centric and ecosystem insights into hepatocellular carcinoma across Asia-Pacific – LEAP

In this white paper, insights on the liver ecosystem are uncovered, with the intention of facilitating action among various stakeholders to reduce liver cancer incidence and mortality in APAC. Read the whitepaper to find out more about the various active initiatives and recommendations for next steps.

Read more

Recent Articles

roche
White Paper
23 August 2023

Building modern hepatocellular carcinoma surveillance programmes: taking steps to address a leading cause of liver cancer death in Asia

In this whitepaper, HCC surveillance programs in Asia were analysed. The learnings from well established HCC surveillance programs, as well as the challenges in areas that…

READ MORE
Untitled presentation
White Paper
14 March 2023

International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma

This white paper, which was developed by a group of experts in biomarker development, provides a framework on best practices to design, execute, and interpret biomarker…

READ MORE
APACMed White Paper Strengthening Healthcare Systems Through the Critical Role of Diagnostics
White Paper
9 December 2022

APACMed White Paper – Strengthening Healthcare Systems Through the Critical Role of Diagnostics

Diagnostic technologies are used across the entire patient journey of multiple disease states, and provide the tools to prevent, detect, and monitor the required interventions. Despite…

READ MORE
Load more articles

You May Also Like

Expert Opinions
27 June 2024

The implications of identifying and managing HCC surveillance patients in General Practice

Read More

Be the first to receive updates, event opportunities, and thought leadership insights.

The information contained in this website is intended for healthcare professionals only.
Click “OK” if you are a healthcare professional.

OK